Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| beta-Lactamases | 6 | 2024 | 304 | 1.490 |
Why?
|
| Klebsiella pneumoniae | 5 | 2024 | 249 | 1.240 |
Why?
|
| Klebsiella Infections | 4 | 2024 | 144 | 1.110 |
Why?
|
| Malawi | 12 | 2024 | 300 | 0.810 |
Why?
|
| Anti-Bacterial Agents | 10 | 2024 | 7407 | 0.760 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 5 | 2024 | 585 | 0.720 |
Why?
|
| Genome, Bacterial | 4 | 2024 | 785 | 0.560 |
Why?
|
| Chloramphenicol | 3 | 2024 | 67 | 0.550 |
Why?
|
| beta-Lactam Resistance | 1 | 2017 | 73 | 0.550 |
Why?
|
| Escherichia coli Infections | 2 | 2019 | 518 | 0.550 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2024 | 1936 | 0.510 |
Why?
|
| Escherichia coli | 6 | 2024 | 4201 | 0.470 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2021 | 187 | 0.460 |
Why?
|
| Phylogeny | 6 | 2024 | 2809 | 0.390 |
Why?
|
| Genomics | 5 | 2024 | 5828 | 0.360 |
Why?
|
| Sepsis | 3 | 2022 | 2585 | 0.360 |
Why?
|
| Bacteria | 2 | 2021 | 2190 | 0.350 |
Why?
|
| Drug Resistance, Bacterial | 4 | 2024 | 1048 | 0.290 |
Why?
|
| Hospitals | 3 | 2024 | 3881 | 0.260 |
Why?
|
| Klebsiella | 1 | 2024 | 49 | 0.240 |
Why?
|
| Bacteremia | 2 | 2022 | 978 | 0.230 |
Why?
|
| Pneumococcal Infections | 2 | 2020 | 501 | 0.230 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2021 | 144 | 0.180 |
Why?
|
| Carbapenems | 1 | 2021 | 123 | 0.170 |
Why?
|
| Cross Infection | 3 | 2024 | 1422 | 0.170 |
Why?
|
| Enterobacteriaceae | 1 | 2021 | 161 | 0.170 |
Why?
|
| Vibrio cholerae | 1 | 2024 | 791 | 0.150 |
Why?
|
| Cholera | 1 | 2024 | 747 | 0.150 |
Why?
|
| Salmonella Infections | 1 | 2019 | 172 | 0.150 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 1747 | 0.140 |
Why?
|
| Gastroenteritis | 1 | 2019 | 236 | 0.140 |
Why?
|
| Pneumococcal Vaccines | 2 | 2020 | 397 | 0.140 |
Why?
|
| Multilocus Sequence Typing | 1 | 2017 | 101 | 0.140 |
Why?
|
| Genes, Bacterial | 2 | 2019 | 1073 | 0.140 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 347 | 0.140 |
Why?
|
| Metagenomics | 1 | 2020 | 463 | 0.130 |
Why?
|
| Bacterial Capsules | 1 | 2017 | 241 | 0.130 |
Why?
|
| Plasmids | 1 | 2021 | 2261 | 0.130 |
Why?
|
| Streptococcus pneumoniae | 2 | 2020 | 730 | 0.130 |
Why?
|
| Africa South of the Sahara | 3 | 2024 | 745 | 0.110 |
Why?
|
| Biological Evolution | 1 | 2019 | 1075 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2019 | 6567 | 0.100 |
Why?
|
| Cephalosporins | 2 | 2022 | 198 | 0.090 |
Why?
|
| Fever | 1 | 2018 | 1618 | 0.090 |
Why?
|
| Population Surveillance | 2 | 2018 | 2598 | 0.090 |
Why?
|
| Public Health | 1 | 2023 | 2672 | 0.080 |
Why?
|
| Africa | 2 | 2024 | 714 | 0.080 |
Why?
|
| Urban Population | 1 | 2017 | 2036 | 0.080 |
Why?
|
| Child | 7 | 2024 | 80152 | 0.070 |
Why?
|
| Vaccines, Conjugate | 2 | 2020 | 328 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3499 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 761208 | 0.070 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2024 | 221 | 0.060 |
Why?
|
| Prophages | 1 | 2024 | 39 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2024 | 42224 | 0.060 |
Why?
|
| Bacterial Proteins | 3 | 2021 | 3836 | 0.050 |
Why?
|
| Prevalence | 4 | 2024 | 15721 | 0.050 |
Why?
|
| Hospitalization | 2 | 2021 | 10707 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 21365 | 0.050 |
Why?
|
| Vietnam | 1 | 2023 | 406 | 0.050 |
Why?
|
| Bacterial Vaccines | 1 | 2024 | 399 | 0.050 |
Why?
|
| Genotype | 2 | 2024 | 12985 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2021 | 565 | 0.040 |
Why?
|
| Infant | 4 | 2024 | 36169 | 0.040 |
Why?
|
| Young Adult | 3 | 2024 | 59221 | 0.040 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2019 | 237 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1751 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 400 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2024 | 26199 | 0.030 |
Why?
|
| Serotyping | 1 | 2017 | 325 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 221119 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 342 | 0.030 |
Why?
|
| Carrier State | 1 | 2020 | 522 | 0.030 |
Why?
|
| Adolescent | 3 | 2024 | 88298 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 1450 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 39957 | 0.030 |
Why?
|
| Biofilms | 1 | 2019 | 625 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 80674 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2019 | 2846 | 0.020 |
Why?
|
| Male | 4 | 2024 | 360693 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1882 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 54435 | 0.020 |
Why?
|
| Female | 4 | 2024 | 392544 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14610 | 0.020 |
Why?
|
| Disease Management | 1 | 2018 | 2507 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 5333 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 3369 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3634 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14675 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20119 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15920 | 0.010 |
Why?
|
| Risk Factors | 1 | 2024 | 74239 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 220853 | 0.010 |
Why?
|
Concepts
(93)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_